Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 30;57(S1):101-111.
doi: 10.5045/br.2022.2022036.

Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases

Hyojin Ahn  1 , Raeseok Lee  1   2 , Sung-Yeon Cho  1   2 , Dong-Gun Lee  1   2
Affiliations
Review

Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases

Hyojin Ahn et al. Blood Res. .

Abstract

Invasive fungal infections (IFIs) are common causes of mortality and morbidity in patients with hematologic diseases. Delayed initiation of antifungal treatment is related to mortality. Aspergillus sp. is the leading cause of IFI followed by Candida sp. Diagnosis is often challenging owing to variable conditions related to underlying diseases. Clinical suspect and prompt management is important. Imaging, biopsy, and non-culture-based tests must be considered together. New diagnostic procedures have been improved, including antigen-based assays and molecular detection of fungal DNA. Among hematologic diseases, patients with acute myeloid leukemia, myelodysplastic syndrome, recipients of hematopoietic stem cell transplantation are at high risk for IFIs. Antifungal prophylaxis is recommended for these high-risk patients. There are continuous attempts to achieve ideal management of IFIs. Scoring system for quality control has been developed with important recommendations of current guidelines. Higher adherence to guidelines is related to decreased mortality in IFIs.

Keywords: Diagnosis; Hematologic diseases; Invasive fungal infections; Quality control; Treatment.

PubMed Disclaimer

Conflict of interest statement

Authors’ Disclosures of Potential Conflicts of Interest

No potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1
Diagnosis of fungal pneumonia in patients with hematologic diseases. a)Evidence of neutrophil count (<500 cells/mL) followed the guideline [14]. Abbreviations: ANC, absolute neutrophil count; BAL, broncho- alveolar lavage; BDG, (1→3) beta- D-glucan; CT, computed tomo-graphy; GM, galactomannan; PCR, polymerase chain reaction.
See this image and copyright information in PMC

References

    1. Edwards JE., Jr. Diagnosis and treatment of fungal infections. In: Jameson JL, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J, eds. Harrison's principles of internal medicine. 20th ed. New York, NY: McGraw-Hill Education, 2018:1515–38.
    1. Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med. 2018;33:256–76. doi: 10.3904/kjim.2018.036. - DOI - PMC - PubMed
    1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54. doi: 10.1056/NEJMoa022139. - DOI - PubMed
    1. Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis. 1999;34:213–20. doi: 10.1016/S0732-8893(99)00035-8. - DOI - PubMed
    1. Shin JH, Won EJ, Kim SH, et al. A multicenter study of antifungal use and species distribution and antifungal susceptibilities of candida isolates in South Korea. J Mycol Infect. 2020;25:10–6. doi: 10.17966/JMI.2020.25.1.10. - DOI